| JAK2 | JakA | TK | 8bx6 | A | B | cerdulatinib | Human | 15042 | 0.41 | |
| JAK2 | JakA | TK | 8bx6 | A | A | cerdulatinib | Human | 15033 | 0.41 | |
| JAK2 | JakA | TK | 4bbf | D | | (2r)-n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]pyrrolidine-2-carboxamide | Human | 3663 | 0.69 | |
| PIK3CG (p110g) | PIK | Atypical | 7jwe | A | | gedatolisib | Human | 13412 | 0.40 | |
| CDK2 | CDK | CMGC | 2xnb | A | A | 3,4-dimethyl-5-(2-{[(1z)-4-piperazin-1-ylcyclohexa-2,4-dien-1-ylidene]amino}pyrimidin-4-yl)-1,3-thiazol-2(3h)-one | Human | 4217 | 0.47 | |
| CDK2 | CDK | CMGC | 1pxn | A | A | 4-[4-(4-methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol | Human | 4383 | 0.42 | |
| AURKA (AurA) | Aur | Other | 2xne | A | | 3-chloro-n-(4-morpholin-4-ylphenyl)-6-pyridin-3-ylimidazo[1,2-a]pyrazin-8-amine | Human | 7221 | 0.45 | |
| CDK2 | CDK | CMGC | 1oiq | A | | n-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]acetamide | Human | 4379 | 0.42 | |
| TTK | TTK | Other | 5ljj | A | | n~6~-cyclohexyl-n~2~-(4-morpholin-4-ylphenyl)-9h-purine-2,6-diamine | Human | 7092 | 0.44 | |
| EPHB4 (EphB4) | Eph | TK | 2xvd | A | A | {4-methyl-3-[(1-methylethyl)(2-{[3-(methylsulfonyl)-5-morpholin-4-ylphenyl]amino}pyrimidin-4-yl)amino]phenyl}methanol | Human | 363 | 0.40 | |
| MAPK1 (Erk2) | MAPK | CMGC | 5ngu | A | | 2-[2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one | Human | 7991 | 0.45 | |
| JAK2 | JakA | TK | 4aqc | B | B | 8-(4-methylsulfonylphenyl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine | Human | 3676 | 0.44 | |
| JAK2 | JakA | TK | 4aqc | A | A | 8-(4-methylsulfonylphenyl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine | Human | 3720 | 0.44 | |
| CDK2 | CDK | CMGC | 3eid | A | A | (2s)-1-(dimethylamino)-3-(4-{[4-(6-morpholin-4-ylpyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-yl]amino}phenoxy)propan-2-ol | Human | 4386 | 0.42 | |
| AURKA (AurA) | Aur | Other | 3uo5 | A | | 4-{[4-(phenylamino)pyrimidin-2-yl]amino}benzoic acid | Human | 2045 | 0.40 | |
| SYK | Syk | TK | 4puz | B | | 6-(1h-indazol-6-yl)-n-[4-(morpholin-4-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine | Human | 1153 | 0.42 | |
| EGFR | EGFR | TK | 3lzb | B | | n-[3-(5-{2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl}imidazo[2,1-b][1,3]thiazol-6-yl)phenyl]-2-phenylacetamide | Human | 810 | 0.50 | |
| EGFR | EGFR | TK | 3lzb | D | | n-[3-(5-{2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl}imidazo[2,1-b][1,3]thiazol-6-yl)phenyl]-2-phenylacetamide | Human | 820 | 0.50 | |
| CDK2 | CDK | CMGC | 2uue | A | | 4-methyl-5-{(2e)-2-[(4-morpholin-4-ylphenyl)imino]-2,5-dihydropyrimidin-4-yl}-1,3-thiazol-2-amine | Human | 4515 | 0.59 | |
| EPHB4 (EphB4) | Eph | TK | 2xvd | A | B | {4-methyl-3-[(1-methylethyl)(2-{[3-(methylsulfonyl)-5-morpholin-4-ylphenyl]amino}pyrimidin-4-yl)amino]phenyl}methanol | Human | 372 | 0.40 | |
| EGFR | EGFR | TK | 3lzb | C | | n-[3-(5-{2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl}imidazo[2,1-b][1,3]thiazol-6-yl)phenyl]-2-phenylacetamide | Human | 808 | 0.50 | |
| CDK2 | CDK | CMGC | 3eid | A | B | (2s)-1-(dimethylamino)-3-(4-{[4-(6-morpholin-4-ylpyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-yl]amino}phenoxy)propan-2-ol | Human | 4424 | 0.42 | |
| CDK2 | CDK | CMGC | 2uue | C | | 4-methyl-5-{(2e)-2-[(4-morpholin-4-ylphenyl)imino]-2,5-dihydropyrimidin-4-yl}-1,3-thiazol-2-amine | Human | 4321 | 0.59 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | C | B | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10505 | 0.44 | |
| CDK2 | CDK | CMGC | 2vv9 | A | B | 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1h-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol | Human | 3881 | 0.51 | |
| CDK2 | CDK | CMGC | 2vv9 | A | A | 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1h-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol | Human | 3989 | 0.51 | |
| ITK | Tec | TK | 3qgy | B | A | n-{5-[2-(methylamino)pyrimidin-4-yl]-2-oxo-1,2-dihydropyridin-3-yl}-4-(piperidin-1-yl)benzamide | Human | 52 | 0.42 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | C | A | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10507 | 0.44 | |
| MAPK10 (JNK3) | MAPK | CMGC | 3kvx | A | B | n-[(2z)-4-(3-fluoro-5-morpholin-4-ylphenyl)pyrimidin-2(1h)-ylidene]-4-(3-morpholin-4-yl-1h-1,2,4-triazol-1-yl)aniline | Human | 3430 | 0.53 | |
| PIK3CG (p110g) | PIK | Atypical | 4ful | A | | 4-({4-[3-(piperidin-1-ylcarbonyl)phenyl]pyrimidin-2-yl}amino)benzenesulfonamide | Human | 9242 | 0.40 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6ekd | A | B | 4-(4-methyl-2-methylsulfanyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10502 | 0.42 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | A | A | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10508 | 0.44 | |
| ULK3 | ULK | Other | 6fdz | U | | momelotinib | Human | 10390 | 0.67 | |
| MAPK1 (Erk2) | MAPK | CMGC | 5nhv | A | | 7-[2-(oxan-4-ylamino)pyrimidin-4-yl]-3,4-dihydro-2~{h}-pyrrolo[1,2-a]pyrazin-1-one | Human | 7995 | 0.42 | |
| JAK2 | JakA | TK | 8bxh | A | A | momelotinib | Human | 15032 | 0.67 | |
| JAK2 | JakA | TK | 4bbe | D | | n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]ethanamide | Human | 3726 | 1.00 | |
| JAK2 | JakA | TK | 4aqc | A | B | 8-(4-methylsulfonylphenyl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine | Human | 3696 | 0.44 | |
| JAK2 | JakA | TK | 4bbe | C | | n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]ethanamide | Human | 3649 | 1.00 | |
| JAK2 | JakA | TK | 4bbf | C | | (2r)-n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]pyrrolidine-2-carboxamide | Human | 3644 | 0.69 | |
| JAK2 | JakA | TK | 4bbe | A | | n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]ethanamide | Human | 3670 | 1.00 | |
| JAK2 | JakA | TK | 4d1s | A | B | 2-(5-chloro-2-methylphenyl)-1-methyl-5-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)-1h-pyrrole-3-carboxamide | Human | 3627 | 0.44 | |
| JAK2 | JakA | TK | 4bbe | B | | n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]ethanamide | Human | 3727 | 1.00 | |
| JAK2 | JakA | TK | 4d1s | A | A | 2-(5-chloro-2-methylphenyl)-1-methyl-5-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)-1h-pyrrole-3-carboxamide | Human | 3634 | 0.44 | |
| JAK2 | JakA | TK | 4bbf | B | | (2r)-n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]pyrrolidine-2-carboxamide | Human | 3717 | 0.69 | |
| JAK2 | JakA | TK | 4bbf | A | | (2r)-n-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]pyrrolidine-2-carboxamide | Human | 3723 | 0.69 | |
| JAK2 | JakA | TK | 4aqc | B | A | 8-(4-methylsulfonylphenyl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine | Human | 3679 | 0.44 | |
| JAK2 | JakA | TK | 8bxh | A | B | momelotinib | Human | 15045 | 0.67 | |
| SYK | Syk | TK | 4puz | A | | 6-(1h-indazol-6-yl)-n-[4-(morpholin-4-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine | Human | 1163 | 0.42 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | D | B | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10496 | 0.44 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | B | A | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10506 | 0.44 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | D | A | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10497 | 0.44 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | A | B | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10503 | 0.44 | |
| MAPK10 (JNK3) | MAPK | CMGC | 3kvx | A | A | n-[(2z)-4-(3-fluoro-5-morpholin-4-ylphenyl)pyrimidin-2(1h)-ylidene]-4-(3-morpholin-4-yl-1h-1,2,4-triazol-1-yl)aniline | Human | 3433 | 0.53 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6ekd | A | A | 4-(4-methyl-2-methylsulfanyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10498 | 0.42 | |
| ACVR1 (ALK2) | STKR | TKL | 7c3g | A | B | ~{n}-[4-(4-methylpiperazin-1-yl)phenyl]-4-(2-pyridin-3-yl-6,7-dihydro-4~{h}-pyrazolo[5,1-c][1,4]oxazin-3-yl)pyrimidin-2-amine | Human | 13390 | 0.49 | |
| ACVR1 (ALK2) | STKR | TKL | 6jux | A | B | 4-(1-ethyl-3-pyridin-3-yl-pyrazol-4-yl)-~{n}-(4-piperazin-1-ylphenyl)pyrimidin-2-amine | Human | 12160 | 0.41 | |
| ACVR1 (ALK2) | STKR | TKL | 7nns | B | B | momelotinib | Human | 13464 | 0.67 | |
| ACVR1 (ALK2) | STKR | TKL | 7nns | B | A | momelotinib | Human | 13465 | 0.67 | |
| ACVR1 (ALK2) | STKR | TKL | 7c3g | B | B | ~{n}-[4-(4-methylpiperazin-1-yl)phenyl]-4-(2-pyridin-3-yl-6,7-dihydro-4~{h}-pyrazolo[5,1-c][1,4]oxazin-3-yl)pyrimidin-2-amine | Human | 13391 | 0.49 | |
| ACVR1 (ALK2) | STKR | TKL | 7c3g | B | A | ~{n}-[4-(4-methylpiperazin-1-yl)phenyl]-4-(2-pyridin-3-yl-6,7-dihydro-4~{h}-pyrazolo[5,1-c][1,4]oxazin-3-yl)pyrimidin-2-amine | Human | 13392 | 0.49 | |
| PAK1 | STE20 | STE | 5kbq | A | | [4-methyl-3-[methyl-[2-[(3-methylsulfonyl-5-morpholin-4-yl-phenyl)amino]pyrimidin-4-yl]amino]phenyl]methanol | Human | 7081 | 0.41 | |
| IGF1R | InsR | TK | 3qqu | D | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 997 | 0.41 | |
| IGF1R | InsR | TK | 3qqu | B | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 1020 | 0.41 | |
| IGF1R | InsR | TK | 3qqu | C | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 1014 | 0.41 | |
| IGF1R | InsR | TK | 3qqu | A | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 1024 | 0.41 | |
| MAPK13 (p38d) | MAPK | CMGC | 4eym | A | | 2-(morpholin-4-yl)-n-[4-(pyridin-4-yloxy)phenyl]pyridine-4-carboxamide | Human | 2945 | 0.41 | |
| EGFR | EGFR | TK | 3lzb | A | | n-[3-(5-{2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl}imidazo[2,1-b][1,3]thiazol-6-yl)phenyl]-2-phenylacetamide | Human | 800 | 0.50 | |
| CDK2 | CDK | CMGC | 2xnb | A | B | 3,4-dimethyl-5-(2-{[(1z)-4-piperazin-1-ylcyclohexa-2,4-dien-1-ylidene]amino}pyrimidin-4-yl)-1,3-thiazol-2(3h)-one | Human | 4034 | 0.47 | |
| CDK2 | CDK | CMGC | 3unj | A | | 4-{[4-(phenylamino)pyrimidin-2-yl]amino}benzoic acid | Human | 4498 | 0.40 | |
| ITK | Tec | TK | 3qgy | B | B | n-{5-[2-(methylamino)pyrimidin-4-yl]-2-oxo-1,2-dihydropyridin-3-yl}-4-(piperidin-1-yl)benzamide | Human | 66 | 0.42 | |
| MAPK10 (JNK3) | MAPK | CMGC | 6emh | B | B | 4-(4-methyl-1~{h}-imidazol-5-yl)-~{n}-(4-morpholin-4-ylphenyl)pyridin-2-amine | Human | 10501 | 0.44 | |
| ACVR1 (ALK2) | STKR | TKL | 7c3g | A | A | ~{n}-[4-(4-methylpiperazin-1-yl)phenyl]-4-(2-pyridin-3-yl-6,7-dihydro-4~{h}-pyrazolo[5,1-c][1,4]oxazin-3-yl)pyrimidin-2-amine | Human | 13389 | 0.49 | |
| ACVR1 (ALK2) | STKR | TKL | 6jux | A | A | 4-(1-ethyl-3-pyridin-3-yl-pyrazol-4-yl)-~{n}-(4-piperazin-1-ylphenyl)pyrimidin-2-amine | Human | 12161 | 0.41 | |
